Luan S, Luan J
Sci Rep. 2025; 15(1):7743.
PMID: 40044764
PMC: 11882932.
DOI: 10.1038/s41598-025-89072-3.
Chera A, Stancu-Cretu M, Zabet N, Bucur O
Epigenetics Chromatin. 2024; 17(1):39.
PMID: 39734197
PMC: 11684317.
DOI: 10.1186/s13072-024-00558-2.
Tolu S, Viny A, Amengual J, Pro B, Bates S
Nat Rev Clin Oncol. 2024; 22(2):117-133.
PMID: 39623073
DOI: 10.1038/s41571-024-00972-1.
Kumawat J, Jain S, Misra N, Dwivedi J, Kishore D
Mini Rev Med Chem. 2024; 24(22):2019-2071.
PMID: 38847171
DOI: 10.2174/0113895575309800240526180356.
Kim D, Shin D, Oh S, Kim I, Kim E
Int J Mol Sci. 2024; 25(9).
PMID: 38731939
PMC: 11083267.
DOI: 10.3390/ijms25094723.
Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes.
Matsumoto T, Murakami Y, Yoshida-Sakai N, Katsuchi D, Kanazawa K, Okamura T
Int J Mol Sci. 2024; 25(9).
PMID: 38731802
PMC: 11083213.
DOI: 10.3390/ijms25094583.
A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
Xie L, Xie D, DU Z, Xue S, Wang K, Yu X
Int J Oncol. 2024; 64(4).
PMID: 38391039
PMC: 10901537.
DOI: 10.3892/ijo.2024.5626.
The tumor cell-intrinsic cGAS-STING pathway is associated with the high density of CD8 T cells after chemotherapy in esophageal squamous cell carcinoma.
Matsuishi A, Nakajima S, Kaneta A, Saito K, Fukai S, Sakuma M
Esophagus. 2024; 21(2):165-175.
PMID: 38324215
DOI: 10.1007/s10388-024-01044-0.
Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors.
Alotaibi F, Alshammari K, Alotaibi B, Alsaab H
Front Pharmacol. 2024; 14:1280591.
PMID: 38264532
PMC: 10803447.
DOI: 10.3389/fphar.2023.1280591.
CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer.
Tejedor J, Penarroya A, Gancedo-Verdejo J, Santamarina-Ojeda P, Perez R, Lopez-Tamargo S
Clin Epigenetics. 2023; 15(1):133.
PMID: 37612734
PMC: 10464368.
DOI: 10.1186/s13148-023-01546-1.
Dual roles of demethylation in cancer treatment and cardio-function recovery.
Li X, Shen D, Zhu Z, Lyu D, He C, Sun Y
Redox Biol. 2023; 64:102785.
PMID: 37343447
PMC: 10363477.
DOI: 10.1016/j.redox.2023.102785.
Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.
Cho C, Lin C, Huang H, Yang W, Fei C, Lin H
ACS Chem Biol. 2023; 18(6):1335-1350.
PMID: 37188336
PMC: 10278071.
DOI: 10.1021/acschembio.3c00065.
Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
Zhang J, Huang L, Ge G, Hu K
Adv Sci (Weinh). 2023; 10(7):e2206169.
PMID: 36599655
PMC: 9982594.
DOI: 10.1002/advs.202206169.
Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer.
Das D, Karthik N, Taneja R
Subcell Biochem. 2022; 100:523-555.
PMID: 36301505
DOI: 10.1007/978-3-031-07634-3_16.
Structural Basis of Targeted Imaging and Therapy in Cancer Explorations with the Epigenetic Drugs.
Pandit P, Brahmkhatri V
Subcell Biochem. 2022; 100:503-521.
PMID: 36301504
DOI: 10.1007/978-3-031-07634-3_15.
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.
Wattebled K, Drumez E, Coiteux V, Magro L, Srour M, Chauvet P
Ann Hematol. 2022; 101(6):1321-1331.
PMID: 35352216
DOI: 10.1007/s00277-022-04821-y.
DNA methylation markers in esophageal cancer: an emerging tool for cancer surveillance and treatment.
Wang H, DeFina S, Bajpai M, Yan Q, Yang L, Zhou Z
Am J Cancer Res. 2021; 11(11):5644-5658.
PMID: 34873485
PMC: 8640794.
Intravesical Instillation of Azacitidine Suppresses Tumor Formation through TNF-R1 and TRAIL-R2 Signaling in Genotoxic Carcinogen-Induced Bladder Cancer.
Wang S, Chang Y, Wu M, Yu C, Chen S, Sung W
Cancers (Basel). 2021; 13(16).
PMID: 34439091
PMC: 8392848.
DOI: 10.3390/cancers13163933.
Current Treatment of Juvenile Myelomonocytic Leukemia.
Mayerhofer C, Niemeyer C, Flotho C
J Clin Med. 2021; 10(14).
PMID: 34300250
PMC: 8305558.
DOI: 10.3390/jcm10143084.
Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and Expression.
Linnekamp J, Kandimalla R, Fessler E, de Jong J, Rodermond H, van Bochove G
Cancers (Basel). 2021; 13(10).
PMID: 34068407
PMC: 8153633.
DOI: 10.3390/cancers13102357.
